PL1586320T3 - Stała postać dawkowania zawierająca cytyzynę - Google Patents

Stała postać dawkowania zawierająca cytyzynę

Info

Publication number: PL1586320T3
Authority: PL; Poland
Prior art keywords: cytisine; dosage form; solid dosage; containing solid; tablets
Prior art date: 2004-04-16

Application number

PL05472001T

Other languages

English (en)

Inventor

Vesselin Evgeniev Daskalov

Angel Radoslavov Timchev

Violeta Andreeva Pavlova

Radka Kostova Grozdeva

Vlayko Petrov Tonev

Yanka Ivanova Borissova

Dobrina Hristova Dobreva

Todorka Boncheva Bendurska

Original Assignee

Sopharma Ad

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-16

Filing date

2005-02-02

Publication date

2008-12-31

2005-02-02 Application filed by Sopharma Ad filed Critical Sopharma Ad

2008-12-31 Publication of PL1586320T3 publication Critical patent/PL1586320T3/pl

Links

ANJTVLIZGCUXLD-BDAKNGLRSA-N (-)-Cytisine Natural products C1NC[C@@H]2CN3C(=O)C=CC=C3[C@H]1C2 ANJTVLIZGCUXLD-BDAKNGLRSA-N 0.000 title abstract 4
ANJTVLIZGCUXLD-DTWKUNHWSA-N cytisine Chemical compound C1NC[C@H]2CN3C(=O)C=CC=C3[C@@H]1C2 ANJTVLIZGCUXLD-DTWKUNHWSA-N 0.000 title abstract 4
229940027564 cytisine Drugs 0.000 title abstract 4
229930017327 cytisine Natural products 0.000 title abstract 4
ANJTVLIZGCUXLD-UHFFFAOYSA-N ent-cytisine Natural products C1NCC2CN3C(=O)C=CC=C3C1C2 ANJTVLIZGCUXLD-UHFFFAOYSA-N 0.000 title abstract 4
239000007909 solid dosage form Substances 0.000 title abstract 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000001913 cellulose Substances 0.000 abstract 1
229920002678 cellulose Polymers 0.000 abstract 1
239000008101 lactose Substances 0.000 abstract 1
239000013081 microcrystal Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL05472001T 2004-04-16 2005-02-02 Stała postać dawkowania zawierająca cytyzynę PL1586320T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
BG108686A BG65536B1 (bg)	2004-04-16	2004-04-16	Лекарствена форма, съдържаща цитизин
EP05472001A EP1586320B1 (en)	2004-04-16	2005-02-02	Cytisine containing solid dosage form

Publications (1)

Publication Number	Publication Date
PL1586320T3 true PL1586320T3 (pl)	2008-12-31

Family

ID=34943361

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05472001T PL1586320T3 (pl)	2004-04-16	2005-02-02	Stała postać dawkowania zawierająca cytyzynę

Country Status (6)

Country	Link
EP (1)	EP1586320B1 (pl)
AT (1)	ATE401075T1 (pl)
BG (1)	BG65536B1 (pl)
DE (1)	DE602005008128D1 (pl)
PL (1)	PL1586320T3 (pl)
SI (1)	SI1586320T1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL220354B1 (pl) *	2012-11-19	2015-10-30	Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością	Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania
CN103284319A (zh) *	2013-06-20	2013-09-11	昌宁德康生物科技有限公司	一种金雀花碱替代尼古丁口腔雾化液及其制备方法
PL408608A1 (pl)	2014-06-18	2015-12-21	Pharmacia Polonica Spółka Z Ograniczoną Odpowiedzialnością	Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania
GB201602145D0 (en) *	2016-02-05	2016-03-23	Achieve Pharma Uk Ltd	Salt
HRP20221497T1 (hr)	2016-08-19	2023-02-17	The University Of Bristol	Derivati citizina za liječenje ovisnosti
US11459328B2 (en)	2017-07-24	2022-10-04	Achieve Pharma Uk Limited	Cytisine salts
EP3598968A1 (en)	2018-07-23	2020-01-29	Adamed Pharma S.A.	Solid pharmaceutical cytisine composition
BG67408B1 (bg) *	2019-04-12	2022-01-17	Софарма Ад	Перорален лекарствен състав с растителен алкалоид, за лечение на зависимости

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5977131A (en) *	1997-04-09	1999-11-02	Pfizer Inc.	Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
EP1178045B1 (en) *	1997-04-09	2003-05-28	Pfizer Inc.	Azaindole-ethylamine derivatives as nicotine acetylchlorine receptor binding agents

2004
- 2004-04-16 BG BG108686A patent/BG65536B1/bg unknown
2005
- 2005-02-02 EP EP05472001A patent/EP1586320B1/en not_active Expired - Lifetime
- 2005-02-02 PL PL05472001T patent/PL1586320T3/pl unknown
- 2005-02-02 AT AT05472001T patent/ATE401075T1/de not_active IP Right Cessation
- 2005-02-02 SI SI200530386T patent/SI1586320T1/sl unknown
- 2005-02-02 DE DE602005008128T patent/DE602005008128D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
BG65536B1 (bg)	2008-11-28
EP1586320A1 (en)	2005-10-19
BG108686A (en)	2005-12-30
DE602005008128D1 (de)	2008-08-28
SI1586320T1 (sl)	2009-02-28
ATE401075T1 (de)	2008-08-15
EP1586320B1 (en)	2008-07-16

Similar Documents

Publication	Publication Date	Title
UA108594C2 (uk)	2015-05-25	Одинична дозована фармацевтична форма
TW200505498A (en)	2005-02-16	Sugar-free oral transmucosal solid dosage forms and uses thereof
IL181382A0 (en)	2011-08-01	Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
MX2010004323A (es)	2010-05-05	Formas de dosificacion oral que comprenden acetato de licarbazepina.
IL205504A0 (en)	2011-07-31	Pharmaceutical compositions
EA200801926A1 (ru)	2009-04-28	Таблетки парацетамола с быстрым высвобождением
IL191804A0 (en)	2008-12-29	Solid dispersion containing an active ingredient and tablets for oral administration containing the same
MX2007015480A (es)	2008-04-29	Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
GEP20063882B (en)	2006-07-25	Dosage regimen and pharmaceutical composition for emergency contraception
AP2003002763A0 (en)	2003-03-31	Controlled release formulations for oral administration
MY139913A (en)	2009-11-30	Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
IL150528A0 (en)	2003-02-12	Ibuprofen containing active agent preparation
MY127350A (en)	2006-11-30	Flash-melt oral dose formulations
MXPA06000332A (es)	2006-03-30	Nueva composicion farmaceutica solida que comprende amisulprida.
PL1586320T3 (pl)	2008-12-31	Stała postać dawkowania zawierająca cytyzynę
WO2008079343A3 (en)	2008-08-14	Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
WO2003061557A3 (en)	2003-11-06	Levothyroxine pharmaceutical compositions, methods of making and methods of administration
WO2006020522A3 (en)	2006-08-31	Multiplex drug delivery device
EA201001108A1 (ru)	2011-02-28	Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
WO2003013441A3 (en)	2003-10-30	Levothyroxine compositions and methods
ZA200506992B (en)	2007-04-25	Fibrate tablet and method for the production thereof
MY141008A (en)	2010-02-12	Oral formulations of deoxypeganine and their uses
WO2004014318A3 (en)	2004-10-28	Levothyroxine compositions and methods
WO2007007182A3 (en)	2007-08-23	Solid and liquid dosage forms of an antiepileptic agent
PL1499278T3 (pl)	2005-09-30	Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon